Response to "letter concerning: Clewell (2019) incorporation of <i>in vitro</i> metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene." (UIHT-2020-0053).

Clewell, H J; Campbell, J L; Van Landingham, C; Franzen, A; Yoon, M; Dodd, D E; Andersen, M E; Gentry, P R

Response to "letter concerning: Clewell (2019) incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene." (UIHT-2020-0053).

Clewell, H J; Campbell, J L; Van Landingham, C; Franzen, A; Yoon, M; Dodd, D E; Andersen, M E; Gentry, P R.

Afiliación

Clewell HJ; Research Triangle Park, Ramboll US Corporation, Charlotte, North Carolina, USA.
Campbell JL; Research Triangle Park, Ramboll US Corporation, Charlotte, North Carolina, USA.
Van Landingham C; Ramboll US Corporation, Monroe, Louisiana, USA.
Franzen A; Ramboll US Corporation, Monroe, Louisiana, USA.
Yoon M; ToxStrategies, Inc., Cary, North Carolina, USA.
Dodd DE; Research Triangle Park, The Hamner Institutes for Health Sciences, North Carolina, USA.
Andersen ME; Research Triangle Park, The Hamner Institutes for Health Sciences, North Carolina, USA.
Gentry PR; ToxStrategies, Inc., Cary, North Carolina, USA.

Inhal Toxicol ; 32(9-10): 369-371, 2020 08.

Article en En | MEDLINE | ID: mdl-32900235

Asunto(s)

Cloropreno; Modelos Biológicos; Medición de Riesgo

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cloropreno Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Inhal Toxicol Asunto de la revista: TOXICOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google